Understand how pharmaceutical and biotechnology companies use option and evaluation agreements to assess opportunities and secure future rights using intelligence from 1,419 real-world deals.
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2026 provides comprehensive intelligence on 1,419 option and evaluation deals across the global life sciences industry.
Option and evaluation agreements provide companies with a flexible route to external innovation. Rather than committing immediately to a full licensing, development or acquisition transaction, a company can obtain time and defined rights to evaluate an asset, technology or program before deciding whether to proceed.
For asset owners, these arrangements can provide funding, validation and access to a prospective future partner while preserving an agreed pathway towards a larger transaction.
The structures can vary substantially. Agreements may include evaluation periods, research programs, exclusivity, option fees, exercise payments, development milestones, future licensing rights, acquisition options and detailed conditions governing when and how an option may be exercised.
The report brings this activity together in one resource, enabling users to understand who is entering option and evaluation partnerships, which companies are most active, how future rights are secured, what financial terms have been disclosed and how comparable agreements have been structured in practice.
Rather than simply providing a list of transactions, the report combines market-wide deal analysis with option-structure intelligence, financial benchmarking, leading dealmaker profiles, detailed transaction records and access to publicly available contract documents where available.
It provides a practical intelligence and benchmarking resource for business development, licensing, search and evaluation, external innovation, corporate strategy, R&D strategy, finance and legal teams involved in assessing, structuring or negotiating option-based partnerships.
This provides more meaningful benchmarking than treating individual payments or headline values as standalone measures.
Identify prospective partners, comparable option structures and relevant precedent transactions.
Search and Evaluation and External Innovation teams
Understand which companies are actively assessing technologies, therapeutic areas and development-stage opportunities.
Biotechnology Companies Seeking Partners
Identify organizations with demonstrated willingness to evaluate external technologies and assets before entering larger transactions.
Corporate and Portfolio Strategy teams
Understand how companies are using staged commitments and option structures to build future pipeline opportunities.
R&D Strategy teams
Examine how emerging technologies and development programs are being evaluated through external partnerships.
Competitive and Market Intelligence teams
Track early signals of company interest in technologies, therapeutic areas and potential future pipeline assets.
Finance and Transaction teams
Investigate disclosed option fees, exercise payments, milestones and wider transaction economics.
Legal teams
Review publicly available option and evaluation agreements and precedent provisions to support transaction preparation and negotiation.
The briefing applies the underlying option and evaluation deal intelligence to the customer's own asset, technology or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor evaluation activity, technology and development-stage analysis, option structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2026 provides comprehensive intelligence on 1,419 option and evaluation deals across the global life sciences industry.
Option and evaluation agreements provide companies with a flexible route to external innovation. Rather than committing immediately to a full licensing, development or acquisition transaction, a company can obtain time and defined rights to evaluate an asset, technology or program before deciding whether to proceed.
For asset owners, these arrangements can provide funding, validation and access to a prospective future partner while preserving an agreed pathway towards a larger transaction.
The structures can vary substantially. Agreements may include evaluation periods, research programs, exclusivity, option fees, exercise payments, development milestones, future licensing rights, acquisition options and detailed conditions governing when and how an option may be exercised.
The report brings this activity together in one resource, enabling users to understand who is entering option and evaluation partnerships, which companies are most active, how future rights are secured, what financial terms have been disclosed and how comparable agreements have been structured in practice.
Rather than simply providing a list of transactions, the report combines market-wide deal analysis with option-structure intelligence, financial benchmarking, leading dealmaker profiles, detailed transaction records and access to publicly available contract documents where available.
It provides a practical intelligence and benchmarking resource for business development, licensing, search and evaluation, external innovation, corporate strategy, R&D strategy, finance and legal teams involved in assessing, structuring or negotiating option-based partnerships.
Understand the option and evaluation deal landscape
The report analyzes option and evaluation dealmaking from 2019 to 2026, including:
- Trends in option and evaluation activity by year
- Phase of development at the time of partnering
- Industry sector
- Therapy area
- Technology type
- Most active option and evaluation dealmakers
- Leading transactions by disclosed value
- Reasons companies use option-based partnering structures
- How option and evaluation strategies are evolving
Understand how option and evaluation agreements are structured
Option agreements can bridge the gap between initial evaluation and a larger future transaction.Depending on the agreement and available disclosure, users can investigate areas including:
- Evaluation rights and periods
- Option rights
- Exclusivity during evaluation
- Research and development responsibilities
- Information and data access
- Intellectual property ownership and control
- Option exercise conditions
- Licensing triggers
- Acquisition rights
- Future development responsibilities
- Geographic and commercial rights
- Option fees and exercise payments
- Milestones and royalties
- Governance and decision-making
- Term and termination provisions
Benchmark option and evaluation financial terms
The report provides access to disclosed financial information associated with individual option and evaluation transactions.Depending on the agreement, users can investigate:
- Evaluation fees
- Upfront payments
- Research funding
- Option fees
- Option exercise payments
- Development milestones
- Regulatory milestones
- Commercial milestones
- Royalty arrangements
- Equity investment
- Other disclosed financial consideration
This provides more meaningful benchmarking than treating individual payments or headline values as standalone measures.
Understand the pathway from evaluation to a larger transaction
One of the defining characteristics of an option agreement is that the initial transaction may represent only the first stage of the commercial relationship.The report enables users to examine how companies have created pathways from initial evaluation towards:
- Licensing
- Co-development
- Expanded collaboration
- Commercial rights
- Asset acquisition
- Corporate acquisition
- Other strategic transactions
Identify leading option dealmakers and prospective partners
The report identifies the Top 25 most active option and evaluation dealmakers and provides transaction histories that enable users to investigate their previous activity.This can help users identify:
- Companies actively evaluating external innovation
- Prospective option partners
- Pharmaceutical companies using staged approaches to accessing new assets
- Organizations repeatedly active in particular technologies or therapeutic areas
- Companies interested in relevant development stages
- Competitors using option structures to build future pipelines
- Relevant precedent transactions
Support search and evaluation and external innovation
Option and evaluation transactions can provide particularly useful intelligence on emerging areas of interest.Because these agreements are frequently used before a larger commitment is made, they can reveal which companies are:
- Evaluating new technologies and modalities
- Exploring emerging therapeutic areas
- Assessing early-stage assets
- Securing future rights to promising programs
- Building relationships with innovative biotechnology companies
- Creating strategic optionality around future pipeline opportunities
Learn from real-world option and evaluation contracts
Where publicly available, the report provides access to underlying contract documents for selected transactions.These agreements can provide substantially more detail than company announcements alone, enabling users to examine how parties have documented matters including:
- Evaluation periods
- Option rights
- Exclusivity
- Option exercise mechanisms
- Payments and exercise fees
- Development obligations
- Intellectual property
- Licensing triggers
- Governance
- Future commercial rights
- Termination and continuing rights
Comprehensive option and evaluation deal directory
The report includes a comprehensive directory of 1,419 pharmaceutical and biotechnology option and evaluation deals, providing an extensive resource for identifying relevant precedent transactions and prospective partners.Deals can be investigated by:
- Company
- Therapy area
- Technology type
- Contract availability
Who should use this report?
Business Development and Licensing teamsIdentify prospective partners, comparable option structures and relevant precedent transactions.
Search and Evaluation and External Innovation teams
Understand which companies are actively assessing technologies, therapeutic areas and development-stage opportunities.
Biotechnology Companies Seeking Partners
Identify organizations with demonstrated willingness to evaluate external technologies and assets before entering larger transactions.
Corporate and Portfolio Strategy teams
Understand how companies are using staged commitments and option structures to build future pipeline opportunities.
R&D Strategy teams
Examine how emerging technologies and development programs are being evaluated through external partnerships.
Competitive and Market Intelligence teams
Track early signals of company interest in technologies, therapeutic areas and potential future pipeline assets.
Finance and Transaction teams
Investigate disclosed option fees, exercise payments, milestones and wider transaction economics.
Legal teams
Review publicly available option and evaluation agreements and precedent provisions to support transaction preparation and negotiation.
Turn market-wide option intelligence into company-specific insight
For qualifying customers, the analyst can also provide a Customized Executive Partnering Briefing alongside the report.The briefing applies the underlying option and evaluation deal intelligence to the customer's own asset, technology or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor evaluation activity, technology and development-stage analysis, option structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in option and evaluation dealmaking
Chapter 3 - Overview of option and evaluation deal structure
Chapter 4 - Leading option and evaluation deals
Chapter 5 - Top 25 most active option and evaluation dealmakers
Chapter 6 - option and evaluation deals including contracts directory
Deal directory
TABLE OF FIGURES
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 2cureX
- 2seventy bio
- 3B Pharmaceuticals
- 3D Medicines
- 3SBio
- 3T Biosciences
- 4D Molecular Therapeutics
- 4D Pharma
- 9 Meters Biopharma
- 23andMe
- 48Hour Discovery
- A2 Biotherapeutics
- A2A Pharmaceuticals
- Aarvik Therapeutics
- AB2 Bio
- Abbisko Therapeutics
- Abbott Laboratories
- Abbvie
- AbCellera Biologics
- Abeona Therapeutics
- Abera Bioscience
- Abilita Therapeutics
- Ablaze Pharmaceuticals
- AbSci
- Accent Therapeutics
- Acelyrin
- Acepodia
- Acer Therapeutics
- Ache
- Achilles Therapeutics
- AC Immune
- Acuitas Therapeutics
- Acumen Pharmaceuticals
- Acutus Medical
- Adagene
- Adaptimmune
- Adaptive Phage Therapeutics
- AdaptVac
- ADARx Pharmaceuticals
- Adcendo
- ADC Therapeutics
- Addario Lung Cancer Medical Institute
- Addex Therapeutics
- Adeptrix
- Adhera Therapeutics
- Adimab
- Aditum Bio
- Adneuris Therapeutics
- AdoRx Therapeutics
- ADT Pharmaceuticals
- Advaite
- Advancium Health Network
- Aegea Biotechnologies
- Aelis Pharma
- Aequus Pharmaceuticals
- Aerpio Pharmaceuticals
- Aethon Therapeutics
- Aevi Genomic Medicine
- Aexon Labs
- Affibody
- Affini-T Therapeutics
- Affinia Therapeutics
- AFT Pharmaceuticals
- Agenus Bio
- AgeX Therapeutics
- Agilent Technologies
- Agios Pharmaceuticals
- AgNovos Healthcare
- AIkido Pharma
- Aileron Therapeutics
- Ainos
- AI Proteins
- Aitia
- Ajinomoto
- AJU Pharma
- Akcea Therapeutics
- Akebia Therapeutics
- Akero Therapeutics
- Akston Biosciences
- Albert Einstein College of Medicine
- Aldeyra Therapeutics
- Alector
- Alexion Pharmaceuticals
- Alfasigma
- Aligos Therapeutics
- AlivaMab Discovery Services
- AliveCor
- Alivio Therapeutics
- Alkyon Therapeutics
- Allarity Therapeutics
- Allegro Ophthalmics
- Allergan
- Allergan Aesthetics
- Alligator Bioscience
- Allist Pharma
- Allogene Therapeutics
- Allorion Therapeutics
- Almirall
- Alnylam Pharmaceuticals
- Alphageneron Pharmaceuticals
- Alpha Tau Medical
- Alpine Immune Sciences
- Altamira Therapeutics
- Altavant Sciences
- Alteogen
- Alternavida
- Alumis
- Alverno Clinical Laboratories
- AmacaThera
- Amagma Therapeutics
- Amasa Therapeutics
- Amathus Therapeutics
- Amerimmune
- Amgen
- AmMax Bio
- Amneal Pharmaceuticals
- Amolyt Pharma
- ANANDA Scientific
- Anchiano Therapeutics
- Anergis
- Angelini Pharma
- Angiex
- Angle
- Anima Biotech
- Ankyra Therapeutics
- Antares Pharma
- Antares Therapeutics
- Antengene
- Apellis Pharmaceuticals
- Applied Cells
- Applied DNA Sciences
- Applied StemCell
- Apricity Health
- Aptorum Group
- Aqemia
- Aqilion
- Araris Biotech
- Arbor Biotechnologies
- Arbutus
- ARCA Biopharma
- Arc Bio
- Arcellx
- Arcturus Therapeutics
- Arcus Biosciences
- Ardelyx
- Arecor
- Arecor Therapeutics
- Arena Pharmaceuticals
- Ares Genetics
- argenx
- Argo Biopharma
- AriBio
- Ariceum Therapeutics
- Aridis Pharmaceuticals
- Aristea Therapeutics
- Arkuda Therapeutics
- Arovella Therapeutics
- Arrakis Therapeutics
- ArriVent Biopharma
- Arrowhead Pharmaceuticals
- Arsenal Biosciences
- Artios Pharma
- Artisan Bio
- Artiva Biotherapeutics
- Artizan Biosciences
- Aruvant Sciences
- Asahi Kasei
- Ascentage Pharma
- Ascidian Therapeutics
- ASC Therapeutics
- Asep Medical
- Asher Bio
- Asia Green Biotechnology
- Asieris Pharmaceuticals
- ASKA Pharmaceuticals
- Asklepios Biopharmaceutical
- Aslan Pharma
- Assembly Biosciences
- Astellas Institute for Regenerative Medicine
- Astellas Pharma
- Astellas Pharma US
- Astex Pharmaceuticals
- AstraZeneca
- Astrea Forensics
- ATAI Life Sciences
- Atara Biotherapeutics
- Atavistik Bio
- Ateria Health
- Athebio
- Atlantic Medical International
- Atossa Therapeutics
- Atreca
- Attralus
- Audere
- AuraVax Therapeutics
- Aurigene Discovery Technologies
- Aurora Cannabis
- Autolus
- Autolus Therapeutics
- Avacta
- Avenzo Therapeutics
- AVEO Oncology
- AviadoBio
- Avicenna Biosciences
- Avita Therapeutics
- Avrobio
- Axolabs
- Aytu BioPharma
- Aziyo Biologics
- Azura Ophthalmics
- BASE10 Genetics
- Basilea Pharmaceutica
- Battelle
- Bausch & Lomb
- Bausch Health Companies
- Baxalta
- Baxter International
- Bayer
- Bayer CropScience
- Baylor College
- Baylor College of Medicine
- Baylor Scott and White Research Institute
- Beacon Therapeutics
- Beam Therapeutics
- BeiGene
- Belgian Society of Medical Oncology
- Belharra Therapeutics
- Bellicum Pharmaceuticals
- BeOne Medicines
- BGN Technologies
- Bicycle Therapeutics
- Bill and Melinda Gates Foundation
- Bintai Kinden
- Bio-Rad Laboratories
- Bio-Thera Solutions
- bioAffinity Technologies
- BioAge Labs
- BioArctic AB
- biOasis Technologies
- Biobeat
- Biocaptiva
- BioCardia
- Biocartis
- Biocept
- BioCopy
- Biocytogen
- Biodesix
- Biodextris
- Biofidelity
- Biogen
- Biohaven Pharmaceuticals
- BioInvent
- Biolojic Design
- BioMarin Pharmaceutical
- Biomedical Advanced Research and Development Authority
- BioMotiv
- Biomunex Pharmaceuticals
- BiomX
- Biond Biologics
- BiondVax
- Bioniz Therapeutics
- BioNova Pharmaceuticals
- BioNTech
- BioNuclear
- Biorchestra
- BioSig Technologies
- Biosplice
- Biotheus
- Biotricity
- BioVaxys
- BioVersys
- Bit Bio
- Blackrock Microsystems
- Bliss Biopharmaceutical
- Bloom Science
- Bluebird Bio
- Blue Earth Diagnostics
- Blueprint Medicines
- BlueRock Therapeutics
- Boehringer Ingelheim
- Bohai Biomedical
- Bold Therapeutics
- Bolt Biotherapeutics
- Boragen
- Boston Immune Technologies and Therapeutics
- Boston Pharmaceuticals
- Boston Scientific
- Brammer Bio
- BriaCell Therapeutics
- BridgeBio Pharma
- BrightPath Biotherapeutics
- Bright Peak Therapeutics
- Bristol-Myers Squibb
- Bruker
- Bruno Farmaceutici
- Byondis
- C4 Therapeutics
- C4X Discovery
- Cabaletta Bio
- Caelum Biosciences
- Calder Biosciences
- Califia Pharma
- Camurus
- CanAm Bioresearch
- CANbridge Pharmaceuticals
- Cancer Genetics
- Cancer Research UK
- Cannabix Technologies
- Cannassure Therapeutics
- Capsida Biotherapeutics
- Captor Therapeutics
- Caraway Therapeutics
- Cardea Bio
- Cardiff Oncology
- Cardiovascular Systems
- CarePICS
- Caribou Biosciences
- Caris Life Sciences
- Carisma Therapeutics
- Carmine Therapeutics
- Carnegie Mellon University
- CARsgen
- Cartography Biosciences
- Cascade ProDrug
- Case Western Reserve University
- Catalent
- Catalyst Pharmaceuticals
- CathWorks
- CBD Solutions
- Celcuity
- Celgene
- Cellares
- CellCarta
- Cellectis
- Cellenkos
- Cellistic
- Celltrion
- Cellular Biomedicine
- Celmatix
- Celsius Therapeutics
- Centrexion
- Century Therapeutics
- Cernostics
- Cerveau Technologies
- Cevec Pharmaceuticals
- Champions Oncology
- Chansu Vascular Technologies
- Charles River Laboratories
- CHARM Therapeutics
- Checkmate Pharmaceuticals
- Checkpoint Therapeutics
- Chemify
- Chi-Med
- Chiesi Farmaceutici
- Children's Hospital Boston
- Children's Medical Research Institute
- Chimeric Therapeutics
- Chimeron Bio
- Cholesgen
- ChromaCode
- Chroma Medicine
- Chrysalis BioTherapeutics
- Chugai Pharmaceutical
- CiMaas
- Cimeio Therapeutics
- Circio
- Citius Pharmaceuticals
- City of Hope
- Clavius Pharmaceuticals
- Clearmind Medicine
- ClearPoint Neuro
- Clearside Biomedical
- Cleveland Clinic
- Clover Biopharmaceuticals
- Coalition for Epidemic Preparedness Innovations
- Cocoon Biotech
- Code Biotherapeutics
- Codexis
- Codiak BioSciences
- Coeptis Pharmaceuticals
- Coeptis Therapeutics
- CohBar
- Coherus Biosciences
- CoImmune
- Collplant
- Columbia University
- Combotope Therapeutics
- Comera Life Sciences
- Conatus Pharmaceuticals
- Conduit Pharmaceuticals
- Confo Therapeutics
- Congruence Therapeutics
- Contera Pharma
- Context Therapeutics
- Contineum Therapeutics
- ContraFect
- Convelo Therapeutics
- COPAN
- Corvia Medical
- COUR Pharmaceutical
- Coya Therapeutics
- Creatus Biosciences
- Crescendo Biologics
- CRISPR Therapeutics
- CrossBay Medical
- Cryolife
- CSIRO
- CSL
- CSL Behring
- CSPC Pharmaceutical Group
- CStone Pharmaceuticals
- Cue Biopharma
- Cugene
- Cullgen
- Cullinan Oncology
- Curasight
- Curate Biosciences
- CUREator
- CureVac
- Cureverse
- Curis
- Cutera
- Cybeats Technologies
- Cyclica
- Cyclo Therapeutics
- CYduct Diagnostics
- Cynata Therapeutics
- Cyntar Ventures
- Cypris Medical
- Cyrano Therapeutics
- Cystic Fibrosis Foundation
- Cytiva
- Cytocom
- Cytodyn
- CytomX Therapeutics
- CytoSite Bio
- CytoVale
- CYTOVIA Therapeutics
- Daewoong Pharmaceutical
- Daiichi Sankyo
- Dana-Farber Cancer Institute
- Dartmouth College
- Dayra Therapeutics
- Debiopharm
- Decibel Therapeutics
- Deciphex
- Deep Genomics
- Deerfield Management
- Defence Research and Development Canada
- Defence Therapeutics
- Deinove
- Dementia Discovery Fund
- Denali Therapeutics
- Denovo Biopharma
- Department of Defense
- Department of Veterans Affairs
- Dermata Therapeutics
- Dermelix Biotherapeutics
- Dermira
- Deverra Therapeutics
- Devyser Diagnostics
- Dewpoint Therapeutics
- Dicerna Pharmaceuticals
- DiNAQOR
- Dispatch Bio
- DNA Link
- Door Pharmaceuticals
- DotBio
- Dr. Reddy's Laboratories
- Dragonfly Therapeutics
- Dren Bio
- Drug Farm
- DS Biopharma
- DSM
- DualityBio
- Duke University
- Dunad Therapeutics
- Durect
- Dyadic International
- Dynacure
- Dyno Therapeutics
- DynPort Vaccine Company
- Eagle Pharmaceuticals
- Eckert & Ziegler
- Edesa Biotech
- Editas Medicine
- Edwards Lifesciences
- eFFECTOR Therapeutics
- Eisai
- Elanco
- Eledon Pharmaceuticals
- Elektrofi
- Element Biosciences
- Eligo Bioscience
- Eli Lilly
- Elixirgen Therapeutics
- Elpiscience
- Elsie Biotechnologies
- Emendo Biotherapeutics
- Emergence Therapeutics
- Emergent BioSolutions
- Emmaus Life Sciences
- Emory University
- Empirico
- EMTensor
- Enalare Therapeutics
- Enara Bio
- Endospan
- Energesis Pharmaceuticals
- Enesi Pharma
- Engitix
- Enigma Biomedical
- Enveric Biosciences
- EnWave
- Enzychem Lifesciences
- Enzyvant Science
- EpicentRx
- eQcell
- EQRx
- Equillium
- Erasca
- ErVimmune
- Escugen
- ESSA Pharma
- Eterna Therapeutics
- Eurocine Vaccines
- European Biomedical Research Institute of Salerno
- Evaxion Biotech
- Everads Therapy
- Everest Medicines
- Evofem Biosciences
- EvolveImmune Therapeutics
- Evonetix
- Evon Medics
- Evopoint Biosciences
- EVOQ Therapeutics
- Evotec
- Evox Therapeutics
- Evozyne
- EVQLV
- Exacis Biotherapeutics
- Exelixis
- Exeltis
- Exicure
- Exopharm
- ExpreS2ion Biotechnologies
- Exscientia
- Eyam Vaccines and Immunotherapeutics
- EyePoint Pharmaceuticals
- F-Star Therapeutics
- Fabric Genomics
- Facit
- FairJourney Biologics
- Farapulse
- Fate Therapeutics
- Fauna Bio
- Felix Biotechnology
- Ferring Pharmaceuticals
- Fibrogen
- FightMND
- FivepHusion
- Flagship Pioneering
- Flare Therapeutics
- Florida State University
- Forge Therapeutics
- Formycon
- Fortis Therapeutics
- Fosun Pharmaceutical
- Fred Hutchinson Cancer Research Center
- Frontier Medicines
- FSD Pharma
- FUJIFILM Cellular Dynamics
- Fusion Pharmaceuticals
- Fuzionaire Radioisotope Technologies
- Gadeta
- Galapagos
- Galderma
- Gamida Cell
- GC Cell
- GC Pharma
- Gedeon Richter
- GE Healthcare
- GEMMA Biotherapeutics
- GenEdit
- Genentech
- General Inception
- Generation Bio
- Generex Biotechnology
- Genesis Therapeutics
- GeneTx Biotherapeutics
- Genevant Sciences
- GenFleet Therapeutics
- Genialis
- Genmab
- Genocea Biosciences
- Genome and Company
- Genome Biologics
- GenomeSmart
- Genoox
- Gensaic
- Genzyme
- George Washington University
- German Cancer Research Center
- Gicell
- Gilead Sciences
- Gilgamesh Pharmaceuticals
- Glaukos
- Global Alzheimer's Platform (GAP)
- Global Blood Therapeutics
- Global Cancer Technology
- Global Coalition for Adaptive Research
- Glycotope Biotechnology
- Glytherix
- Goldfinch Bio
- Gossamer Bio
- Grail
- Graphite Bio
- Graviton Bioscience
- Greenwich LifeSciences
- Gritstone Bio
- GSK
- Gurnet Point Capital
- GV20 Therapeutics
- Gyroscope Therapeutics
- Hadassah Medical Center
- Halozyme Therapeutics
- HanchorBio
- Hansa Biopharma
- Harbinger Health
- Harpoon Therapeutics
- Harvard Medical School
- HavaH Therapeutics
- Haystack Oncology
- HCW Biologics
- Healx
- Heartseed
- Hebei Senlang Biotechnology
- Hebrew University of Jerusalem
- Heidelberg Pharma
- Helius Medical Technologies
- Helmholtz Zentrum Munchen
- Helocyte
- Henlius Biotech
- Hepalys Pharma
- HepaTx
- Heqet Therapeutics
- Herantis
- HiFiBio
- Hikma Pharmaceuticals
- Hillstream BioPharma
- Histogen
- HitGen
- HMNC Brain Health
- Hoffmann La Roche
- Homology Medicines
- Hookipa Pharma
- Hopstem Biotechnology
- Horizon Therapeutics
- Hospital for Sick Children
- Hoth Therapeutics
- HotSpot Therapeutics
- Houston Methodist Research Institute
- Huadong Medicine
- Huahui Health
- Hubro Therapeutics
- Hummingbird Bioscience
- Hutchmed
- I-mab
- i2O Therapeutics
- IASO Biotherapeutics
- Icagen
- Icahn School of Medicine at Mount Sinai
- Iconic Therapeutics
- Iconovo
- IDEAYA Biosciences
- Idorsia
- IFM Therapeutics
- Ifowonco Informatics
- IGAN Biosciences
- Ikarovec
- Iksuda Therapeutics
- Iktos
- Illumina
- Imbrium Therapeutics
- Immatics Biotechnologies
- Immix Biopharma
- Immuneering
- Immune Regulation
- Immune System Regulation
- ImmuNext
- Immunicom
- ImmunityBio
- ImmunoBiochem
- Immunocore
- ImmunoGen
- Immunome
- Immunomic Therapeutics
- ImmunoTek Bio Centers
- Immunovia
- Immunscape
- Immuron
- Immusoft
- Immutep
- IMPACT-AML
- Imperial College London
- Imugene
- Imunon
- IMV
- In4Derm
- Incyclix Bio
- Incyte
- Indapta Therapeutics
- Indiana University
- Indivior
- InduPro Therapeutics
- Infinity Pharmaceuticals
- InflammX Therapeutics
- iNGENu
- Inhibrx
- Inmagene Biopharmaceuticals
- Innate Pharma
- Innovation Pharmaceuticals
- Innovent Biologics
- Insilico Medicine
- Insitro
- InSphero
- Inspira Technologies
- InspireMD
- Inspirna
- Institut Curie
- Institute for Research in Immunology and Cancer - Commercialization of Research
- Institute of Bioengineering and Nanotechnology
- Institute of Molecular and Clinical Ophthalmology Basel
- Institut Pasteur
- Intact Therapeutics
- Intarcia Therapeutics
- Intas Pharmaceuticals
- Integumen
- IntelGenx
- Intellia Therapeutics
- Intellikine
- IntoCell
- Intract Pharma
- iNtRON Biotechnology
- Invenra
- Inventiva
- InxMed
- iOncologi
- iOnctura
- Ionis Pharmaceuticals
- IONTAS
- IOVaxis Therapeutics
- iProgen Biotech
- Ipsen
- Ironwood Pharmaceuticals
- Irras
- Isoprene Pharmaceuticals
- iSTAR Medical
- Italfarmaco
- iTeos Therapeutics
- ITM Isotopen Technologien
- Iveric Bio
- Ivy Brain Tumor Center
- Jacobio Pharmaceuticals
- JanOne
- Janssen Biotech
- Janssen Pharmaceuticals
- Janssen Pharmaceutica NV
- Janssen Research & Development
- Jasper Therapeutics
- Jazz Pharmaceuticals
- JCR Pharmaceuticals
- Jhpiego
- Jiangsu Alphamab
- Jiangsu Hansoh Pharmaceutical
- Jiangsu Hengrui Pharmaceuticals
- JiKang Therapeutics
- Johns Hopkins University
- Johnson & Johnson
- Johnson & Johnson Innovation
- Jomo Kenyatta University of Agriculture and Technology
- Jorna Therapeutics
- Joslin Diabetes Center
- Joyo Pharmatech
- Jubilant Therapeutics
- Junshi Biosciences
- Jura Bio
- JW Therapeutics
- K2 Therapeutics
- KAHR Medical
- Kainos Medicines
- Kairos Pharma
- Kaken Pharmaceutical
- Kalbe Genexine Biologics
- KaliVir Immunotherapeutics
- Kansas State University
- Karolinska University Hospital
- Karveer Meditech
- KDAc Therapeutics
- Kedalion Therapeutics
- Kedrion
- KeifeRx
- Kelonia Therapeutics
- Kelun-Biotech Biopharmaceutical
- KemPharm
- Kestrel Therapeutics
- Kezar Life Sciences
- Kindeva Drug Delivery
- Kindred Bio
- Kineta
- Kiniksa Pharmaceuticals
- KinoPharma
- Kiora Pharmaceuticals
- Kite Pharma
- Klaria
- KM Biologics
- Know Labs
- Krankenhaus Nordwest
- KSQ Therapeutics
- Kubota Vision
- Kukbo
- Kura Oncology
- Kymera Therapeutics
- Kyn Therapeutics
- Kyorin Pharmaceutical
- Kyowa Hakko Kirin
- Kyowa Hakko Kirin Pharmaceuticals
- kyron.bio
- Kyverna Therapeutics
- L'Oreal
- LabGenius Therapeutics
- Laboratoires Thea
- Laboratorios Ordesa
- Laborie Medical Technologies
- La Jolla Institute for Allergy & Immunology
- Lantern Pharma
- Lantheus Holding
- Leap Therapeutics
- LegoChem Biosciences
- LeMaitre Vascular
- LEO Pharma
- Les Laboratoires Servier
- Leveragen
- LG Chem
- LG Life Sciences
- LianBio
- Ligand Pharmaceuticals
- Light Chain Bioscience
- Likarda
- Liminal BioSciences
- Lineage Cell Therapeutics
- Linnaeus Therapeutics
- Lipidor
- Lipocine
- LipoVac
- Liquid Biosciences
- Lisata Therapeutics
- Livzon Mabpharm
- LogicBio Therapeutics
- Lonza
- Lovell Government Services
- LSU Health Sciences Center
- LTS Lohmann Therapie-Systeme
- LTZ Therapeutics
- Lumen Biomedical
- Luminary Therapeutics
- Luminostics
- Lundbeck
- Lupagen
- Lupus Therapeutics
- Lyell Immunopharma
- Lysogene
- Mabylon
- Macomics
- Macrogenics
- Magenta Therapeutics
- Magle Chemoswed
- MAIA Biotechnology
- Mainz Biomed
- Mainz University Medical Centre
- Mallinckrodt Pharmaceuticals
- Mammoth Biosciences
- Manhattan BioSolutions
- MannKind Biopharmaceuticals
- Marengo Therapeutics
- Maruho
- Masimo
- Massachusetts General Hospital
- Massachusetts Institute of Technology
- Matchpoint Therapeutics
- Matinas Biopharma
- MaveriX Oncology
- Max-Planck
- Mayo Clinic
- MC2 Therapeutics
- McQuade Center for Strategic Research and Development
- MD Anderson Cancer Center
- MD Matrix
- Mediar Therapeutics
- Medical City North Hills
- Medical College of Georgia
- Medical Technology Enterprise Consortium
- Medical University South Carolina
- Medice Arzneimittel Pütter
- MEDiC Life Sciences
- Medicure
- Medidata Solutions
- MediGene
- MediLink Therapeutics
- Medtronic
- MeiraGTx
- Melior Pharmaceuticals
- Memorial Sloan Kettering Cancer Center
- Memo Therapeutics
- Menarini
- Merck and Co
- Merck Animal Health
- Merck KGaA
- Merck Sharpe & Dohme
- Merdury Biopharmaceutical
- Mereo BioPharma
- Mersana Therapeutics
- Merus
- Merz
- Mesoblast
- Mestag Therapeutics
- Metagenomi
- Methodist Hospital Houston
- MetVital
- Microbot Medical
- MicroQuin
- Millennium
- MiMedx
- Mimetas
- MiNA Therapeutics
- MindBio Therapeutics
- MindPeak
- MiNK Therapeutics
- Mirati Therapeutics
- Mirimus
- Miroculus
- Mirror Biologics
- miR Scientific
- Mirum Pharmaceuticals
- Mitokinin
- Mitsubishi Chemical
- Mitsubishi Tanabe Pharma
- MockV Solutions
- Moderna
- Modulus Discovery
- Molecular Partners
- Molecular Templates
- Moleculin Biotech
- Molecure
- MOMA Therapeutics
- Monopar Therapeutics
- Montefiore Health System
- Monte Rosa Therapeutics
- Morphic Therapeutic
- MorphoSys
- Mor Research Applications
- Mosaic ImmunoEngineering
- Mount Sinai Health System
- MSD
- MS Pharma
- Multimmune
- Multiply Labs
- Mundipharma
- Munich Technical University
- Murdoch Childrens Research Institute
- MustGrow Biologics
- MycoMedica Life Sciences
- Mydecine Group
- Myeloid Therapeutics
- Myeloma Investment Fund
- Mymetics
- myNEO
- Myovant Sciences
- Myriad Genetics
- Myricx Bio
- Nacuity Pharmaceuticals
- Nanjing Leads Biolabs
- Nanoform
- NanoViricides
- Nantes University
- Napo EU
- Napo Pharmaceuticals
- Natera
- National Cancer Institute
- National Comprehensive Cancer Network (NCCN)
- National Institute of Allergy and Infectious Diseases
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institutes of Health
- Nationwide Children’s Hospital
- Navitor Pharmaceuticals
- NBE Therapeutics
- NEC
- Nectin Therapeutics
- Nektar Therapeutics
- Nelum Pharma
- Nemysis
- NeoDynamics
- NeoImmuneTech
- Neomorph
- Neotope
- Nerviano Medical Sciences
- Nestle Health Science
- NeuBase Therapeutics
- NeuExcell
- Neumentum
- NeuraLight
- Neuraly
- NeurAxis
- Neuraxpharm
- Neurgain Technologies
- Neuro3 Therapeutics
- Neurocrine Biosciences
- NeuroFront
- Neurogene
- NeurOp
- Neurophth Therapeutics
- NeuroRx
- NeuroSense Therapeutics
- Newron Pharmaceuticals
- New York Presbyterian/Columbia
- Neximmune
- NextCure
- Next Science
- Nicox
- Nightingale Health
- Nihon Medi-Physics
- Nimble Therapeutics
- Nippon Shinyaku
- NJ Bio
- Nkarta Therapeutics
- NLS Pharmaceutics
- Nona Biosciences
- Nordic Nanovector
- Nordion
- NorthBay Healthcare
- North Carolina State University
- Nosis Biosciences
- Novaremed
- Novartis
- Novavax
- Novellus Therapeutics
- Novocure
- Novo Nordisk
- Novosound
- nRichDX
- Nuance Pharma
- Nucleix
- Numab
- NuProbe
- Nurix Therapeutics
- Nutriband
- Nuvectis Pharma
- Nuvothera
- NYU Grossman School of Medicine for Preclinical and Clinical Research
- NYU Langone Medical Center
- Obsidian Therapeutics
- Ohara Pharma
- OKYO Pharma
- Olema Oncology
- OliX Pharmaceuticals
- Omega Laboratories
- Omega Therapeutics
- Ona Therapeutics
- Onco-Innovations
- OncoArendi Therapeutics
- Oncoceutics
- OncoCyte
- Oncodesign
- OncoHost
- Oncology Venture
- Oncolytics Biotech
- OncoMyx Therapeutics
- OncoNano Medicine
- OncoSec Medical
- OncoVent
- Oncovir
- ONK Therapeutics
- OnKure
- Ono Pharmaceutical
- Onward Therapeutics
- Opsis Therapeutics
- Optellum
- Optieum Biotechnologies
- Oragenics
- Orbis Medicines
- Orbit Biomedical
- Orchestra BioMed
- Orexo
- Organon
- ORIC Pharmaceuticals
- Orient EuroPharma
- Origami Therapeutics
- Orion
- Orion Biotechnology
- Orna Therapeutics
- Ortho Regenerative Technologies
- Ortoma
- Orum Therapeutics
- Oscotec
- OSE Immunotherapeutics
- Osivax
- Ossianix
- OTR Therapeutics
- Otsuka
- Ovensa
- Ovid Therapeutics
- Oxford BioMedica
- Oxford Biomedica Solutions
- Oxford BioTherapeutics
- Oyster Point Pharma
- Palleon Pharmaceuticals
- Panbela Therapeutics
- Pandion Therapeutics
- Pantherna Therapeutics
- Papyrus Therapeutics
- Parabilis Medicines
- Paragon Genomics
- Passage Bio
- Path BioAnalytics
- Pathogen and Microbiome Institute
- PAVmed
- PDC*line Pharma
- Pearl Bio
- PEAR Therapeutics
- PegBio
- PeptiDream
- Personalis
- PersonGen BioTherapeutics
- Pfenex
- Pfizer
- PharmaEngine
- PharmaJet
- PharmaTher
- Pharming Group
- PHAXIAM Therapeutics
- Phenomic AI
- Philogen
- Phio Pharmaceuticals
- Phost’in Therapeutics
- PierianDx
- Pieris Pharmaceuticals
- Pierre Fabre
- PineTree Therapeutics
- Pionyr Immunotherapeutics
- Plexium
- Plus Therapeutics
- PolyNovo Biomaterials
- Polyphor
- Poolbeg Pharma
- Portage Biotech
- Poseida Therapeutics
- Praedicare
- Praxis Precision Medicines
- Precision BioSciences
- Prek Leap National Institute of Agriculture in Phnom Penh
- Prellis Biologics
- Prelude Therapeutics
- Presage Biosciences
- Prevail Therapeutics
- Prime Medicine
- Processa Pharmaceuticals
- ProfoundBio
- ProFound Therapeutics
- Progenity
- Prokarium
- ProMed Pharma LLC
- Proscia
- Protalix BioTherapeutics
- Proteomics International
- Proteovant Therapeutics
- Prothena
- Provention Bio
- Providence Therapeutics
- Provista Diagnostics
- Psycheceutical Bioscience
- Puerto Rico Government
- Pulmatrix
- Puma Biotechnology
- Purdue Pharma
- Purespring Therapeutics
- PureTech Health
- Purple Biotech
- Q32 Bio
- QBiotics
- QIAGEN
- Qualigen
- QuantalRF
- Quantum Leap Health Care Collaborative
- Quebec Consortium for Drug Discovery
- Queensland Institute of Medical Research (QIMR)
- Queensland University of Technology
- Quell Therapeutics
- Quoin Pharmaceuticals
- QureTech Bio
- Quris-AI
- R-Pharm
- Rabin Medical Center (Beilinson Hospital)
- Race Oncology
- Radiance Biopharma
- Radionetics Oncology
- Radiopharm Theranostics
- Rafael Pharmaceuticals
- Ragon Institute
- Rallybio
- Rani Therapeutics
- RayzeBio
- Recce Pharmaceuticals
- Recludix Pharma
- ReCode Therapeutics
- Recursion
- RedHill Biopharma
- RefleXion Medical
- Regeneron Pharmaceuticals
- Regenstrief Institute
- Regenxbio
- Regional Cancer Institute of Montpellier
- Regor Therapeutics
- Regranion
- Relay Therapeutics
- Relief Therapeutics
- Remedium Bio
- Remix Therapeutics
- ReNAgade Therapeutics
- RenalytixAI
- ReNeuron
- Renovaro BioSciences
- Repare Therapeutics
- Replicel Life Sciences
- Respira Therapeutics
- RespireRx Pharmaceuticals
- Revance Therapeutics
- ReviR Therapeutics
- ReVision Optics
- Revitope Oncology
- ReviveMed
- Revive Therapeutics
- RevolKa
- Revolution Medicines
- Rgenta Therapeutics
- Rheos Medicines
- Ribometrix
- Riparian Pharmaceuticals
- Ripple Therapeutics
- Roche
- Rockwell Medical
- Roivant Sciences
- Rona Therapeutics
- Roswell Park Cancer Institute
- Rothamsted Research
- RQ Biotechnology
- RS BioTherapeutics
- RubrYc Therapeutics
- Rumpus Therapeutics
- Rune Labs
- Ryvu Therapeutics
- SAB Biotherapeutics
- Saga University
- Sail Biomedicines
- Sairopa
- Salipro Biotech
- Samsung Bioepis
- Samyang Biopharmaceuticals
- Sandoz
- SanegeneBio
- Sangamo Therapeutics
- Sanofi
- Sanofi US Services
- Santen Pharmaceutical
- Santhera Pharmaceuticals
- Sant Joan de Déu-Barcelona Children’s Hospital
- Sapphiros
- Sarah Cannon Research Institute
- Sarepta Therapeutics
- Saturnus Bio
- Schrodinger
- SciClone Pharmaceuticals
- SciNeuro Pharmaceuticals
- Scintomics
- Scipher Medicine
- Scorpion Therapeutics
- Scribe Therapeutics
- Scripps Research Institute
- Scynexis
- Seagen
- Seattle Genetics
- Secarna Pharmaceuticals
- Second Genome
- Selecta Biosciences
- SELLAS Life Sciences Group
- Senda Biosciences
- SEngine Precision Medicine
- Senhwa Biosciences
- Senju Pharmaceutical
- Sensorion
- Senti Biosciences
- Sentieon
- Sentinel Oncology
- Sentynl Therapeutics
- Seres Therapeutics
- Sernova
- Serum Institute of India
- Seven and Eight Biopharmaceuticals
- Seyltx
- Shanghai Fosun Long March Medical Science
- Shanghai Medicilon
- Shape Therapeutics
- Shattuck Labs
- Shenzhen Chipscreen Biosciences
- Shionogi
- Shionogi Pharma
- Shoreline Biosciences
- Showa Denko
- Siemens Healthineers
- Signet International
- Signet Medical Solutions
- Sigyn Therapeutics
- Silence Therapeutics
- Silk Road Therapeutics
- Silo Pharma
- SimBioSys
- Simcere Pharmaceutical
- Simcha Therapeutics
- Singapore Institute of Advanced Medicine
- Singular Genomics Systems
- Sinntaxis
- Sironax
- Sirtex Medical
- SiSaf
- Sixty Degrees Pharmaceuticals
- SK Biopharmaceuticals
- Skye Bioscience
- Skyhawk Therapeutics
- SkylineDX
- Societatea Nationala Nuclearelectrica
- Sofregen Medical
- Solid Biosciences
- Soligenix
- Sona Nanotech
- Sonnet BioTherapeutics
- Sonoma BioTherapeutics
- Sorrento Therapeutics
- Sosei
- Sosei Heptares
- SOTIO
- Sovargen
- Spark Therapeutics
- Sparrow Pharmaceuticals
- Spear Bio
- Spectral AI
- Spectral Medical
- Spencer Health Solutions
- Spherix
- SpikImm
- SpineThera
- SpliceBio
- Spring Bank Pharmaceuticals
- SpringWorks Therapeutics
- Spruce Biosciences
- Stablepharma
- STADA Arzneimittel
- Stahl
- Stallargenes
- Starpharma
- Statera Biopharma
- State University of New York
- Stealth BioTherapeutics
- Stemline Therapeutics
- StemoniX
- St George Street Capital
- Stora Enso
- Storm Therapeutics
- Strand Therapeutics
- StrideBio
- Structured Monitoring Products
- Stuart Therapeutics
- SUDA Pharmaceuticals
- Sumitomo Corporation
- Sumitomo Dainippon Pharma
- Sumitovant Biopharma
- Summit Therapeutics
- SunRock Biopharma
- SunTech Medical
- Suono Bio
- Supernus Pharmaceuticals
- Sutro Biopharma
- Suzhou NeuPharma
- SwanBio Therapeutics
- Swedish Orphan Biovitrum
- Syena
- Symvivo
- Synaffix
- Syndax Pharmaceuticals
- SynerK
- Synlogic
- Syntax Bio
- Synthekine
- Synthetic Biologics
- Syros Pharmaceuticals
- T2 Biosystems
- Tachyon Therapeutics
- Taiho
- Taisho Pharmaceutical
- Taiwan Liposome Company
- Takeda Pharmaceutical
- Takeda Pharmaceuticals U.S.A
- Takeda Ventures
- Talem Therapeutics
- Talix Therapeutics
- TARA Biosystems
- Targovax
- Tautomer Bioscience
- Tavros Therapeutics
- Taysha Gene Therapies
- TB Alliance
- Tcelltech
- Teitur Trophics
- TekCyte
- Tela Bio
- Telix Pharmaceuticals
- Tempest Therapeutics
- Tempus
- TeneoBio
- TeneoOne
- Tentarix Biotherapeutics
- Terray Therapeutics
- Terumo
- Tetra Bio-Pharma
- Tetragenetics
- Teva Pharmaceutical Industries
- Texas A&M University
- Texcell
- TFF Pharmaceuticals
- TG Therapeutics
- Tharimmune
- Theragnostics
- Theralase
- Therapix Bio
- Theriva Biologics
- Thermo Fisher Scientific
- Third Arc Bio
- Thirona Bio
- Thomas Jefferson University
- Tiba Biotech
- Titan Pharmaceuticals
- TiumBio
- Tivic Health Systems
- Tizona Therapeutics
- TNI Medical
- Todos Medical
- Tolmar
- Tome Biosciences
- TONIX Pharmaceuticals
- Torii Pharmaceutical
- Torque Therapeutics
- Totus Medicines
- Toxys
- Trace Matters
- TRACON Pharmaceuticals
- TransCode Therapeutics
- Transgene
- Transition Bio
- TransThera
- Treatment.com International
- TreeFrog Therapeutics
- Trevena
- Treventis
- TRexBio
- TRIANA Biomedicines
- Trio Pharmaceuticals
- Triphase Accelerator
- TriSalus Life Sciences
- TRT Innovations
- Trutino Biosciences
- TScan Therapeutics
- TTC
- Tubulis
- Tufts Medical Center
- Tufts University
- TuHURA Biosciences
- Turnstone Biologics
- Twist Bioscience
- Tyris Therapeutics
- Ubiquigent
- Ubix Therapeutics
- UCB
- Ultragenyx Pharmaceuticals
- Umoja Biopharma
- Undisclosed Company
- Uneedle
- Uni-Bio Science
- Unilever
- UNION Therapeutics
- Uni Targeting Research
- UnitedHealth
- Univercells
- Universite Laval
- University College Cork
- University College London
- University Gottingen
- University Medical Center Groningen
- University of Alberta
- University of Amsterdam
- University of Bonn
- University of British Columbia
- University of California San Francisco
- University of Colorado
- University of Edinburgh
- University of Florida
- University of Houston
- University of Illinois Urbana-Champaign
- University of Kentucky
- University of Lausanne
- University of Leipzig
- University of Leuven
- University of Louisville
- University of L’Aquila
- University of Maryland Baltimore
- University of Massachusetts
- University of Massachusetts Medical School
- University of Melbourne
- University of Michigan
- University of Minnesota
- University of Montreal
- University of North Carolina
- University of Oxford
- University of Pennsylvania
- University of Pittsburgh
- University of Sheffield
- University of Southern California
- University of Texas Medical Branch
- University of Texas Southwestern Medical Center
- University of the Highlands and Islands
- University of Tubingen
- University of Virginia
- University of Washington
- University of Wisconsin
- University of Wisconsin-Madison
- University of Wollongong
- Unnatural Products
- UroGen Pharma
- Urotronic
- Urovant Sciences
- UT Southwestern Medical Center
- UWM Research Foundation
- Valencell
- ValenzaBio
- Valo Therapeutics
- Vanderbilt University
- VantAI
- Variational AI
- Vaxart
- Vaxcyte
- Vaximm
- Vect-Horus
- VectivBio
- VectorBuilder
- VectorY Therapeutics
- VelaVigo
- VenatoRx
- Vensica Medical
- Ventyx Biosciences
- Verastem
- Verge Genomics
- VerImmune
- Vernalis
- Verrica Pharmaceuticals
- Vertex Pharmaceuticals
- Verve Therapeutics
- Vesalius Therapeutics
- Vetophage
- Viatris
- VIB
- Vici Health Sciences
- Victoria University
- ViGeneron
- Vigil Neuroscience
- Vir Biotechnology
- Vitalli Bio
- Vivace Therapeutics
- Vivani Medical
- Vivet Therapeutics
- Vividion Therapeutics
- vivoPharm
- Vivoryon Therapeutics
- Vivtex
- Voluntis
- Vor Biopharma
- Voyager Therapeutics
- VyGen-Bio
- VYNE Therapeutics
- Vyriad
- Washington University in St Louis
- WaVe Lifesciences
- WAVE Life Sciences
- Weill Cornell Medical College
- Weizmann Institute
- Westchester Medical Center Health Network
- Westport Bio
- Whitehawk Therapeutics
- Wisconsin Alumni Research Foundation
- Wistar Institute
- Worldwide Clinical Trials
- WuXi Biologics
- WY Biotech
- X-chem
- Xanadu Bio
- Xencor
- Xenetic Biosciences
- Xenon Pharmaceuticals
- XERIS Pharmaceuticals
- Xiamen Amoytop Biotech
- Xilio Therapeutics
- Xoma
- Xyphos Biosciences
- Y-Biologics
- Y2X Life Sciences
- Yale University
- Yatiri Bio
- Yeda Research and Development Company
- Yield10 Bioscience
- Yissum Research Development
- ZAI Laboratory
- Zambon
- Zealand Pharma
- ZebiAI Therapeutics
- Zelgen
- Zenith Epigenetics
- Zenyaku Kogyo
- Zhejiang Conba Pharmaceutical
- Ziopharm Oncology
- Zomedica
- Zosano Pharma
- Zumutor Biologics
- Zymeworks
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
